A Randomized, Double-Blind, Placebo-Controlled Study of Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
NCT03844061 · RECRUITING · Phase 2
We track 1 ClinicalTrials.gov studies led by Hospital For Special Surgery New York. The portfolio skews toward Phase 2 (1 trials).
1 clinical trials sponsored by Hospital For Special Surgery New York.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
Hospital For Special Surgery New York currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 2.
Hospital For Special Surgery New York conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Hospital For Special Surgery New York currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.